Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Vertex Pharmaceuticals Incorporated    VRTX

Delayed Quote. Delayed  - 04/29 10:00:00 pm
84.34 USD   -2.78%
04/27 VERTEX PHARMACE : reports 1Q loss
04/27 VERTEX PHARMACE : Reports First Quarter 2016 Financial Results
04/19 VERTEX PHARMACE : Enterome signs IBD therapy agreement with Vertex
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
04/25/2016 04/26/2016 04/27/2016 04/28/2016 04/29/2016 Date
85.66(c) 84.14(c) 84.5(c) 86.75(c) 84.34 Last
1 460 054 1 689 817 2 614 905 5 463 306 2 887 997 Volume
-1.31% -1.77% +0.43% +2.66% -2.78% Change
More quotes
Financials ($)
Sales 2016 1 809 M
EBIT 2016 280 M
Net income 2016 81,1 M
Finance 2016 496 M
Yield 2016 -
Sales 2017 2 590 M
EBIT 2017 898 M
Net income 2017 641 M
Finance 2017 1 546 M
Yield 2017 -
P/E ratio 2016 474,30
P/E ratio 2017 36,24
EV / Sales 2016 11,5x
EV / Sales 2017 7,66x
Capitalization 21 375 M
More Financials
Company
Vertex Pharmaceuticals, Inc. engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases in specialty markets.It focuses on development and commercializing therapies for the treatment of cystic fibrosis; infectious... 
More about the company
Surperformance© ratings of Vertex Pharmaceuticals Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on VERTEX PHARMACEUTICALS INC
04/28 VERTEX PHARMACEUTICALS : Patent Issued for Solid Forms of 3-(6-(1-(2,2-Difluorob..
04/28 VERTEX PHARMACEUTICALS : to Announce First Quarter 2016 Financial Results on Apr..
04/27 VERTEX PHARMACEUTICALS : reports 1Q loss
04/27 VERTEX PHARMACEUTICALS : Reports First Quarter 2016 Financial Results
04/21 VERTEX PHARMACEUTICALS : New Fenamates Study Findings Have Been Reported from Ve..
04/19 VERTEX PHARMACEUTICALS : Enterome signs IBD therapy agreement with Vertex
04/18 S&P 500 MOVERS : Chk, has
04/18 VERTEX PHARMACEUTICALS : Nivalis Therapeutics Appoints David Rodman, MD as Chief..
More news
Sector news : Bio Therapeutic Drugs
08:49aDJCancer Drugs Entice Big Buyers -- WSJ
08:49aDJAbbott to Acquire St. Jude -- WSJ
08:46aDJSanofi CEO Seeks Talks With Medivation Over $9.3 Billion Offer -- Update
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
04/28 WALL STREET BREAKFAST : BOJ Roils Markets By Not Expanding Stimulus
04/27 Vertex Pharmaceuticals' (VRTX) CEO Jeffrey Leiden on Q1 2016 Results - Earnin..
04/27 Vertex Q1 top line up 201%; non-GAAP EPS up 115%; shares off 1% after hours
04/27 Vertex Pharmaceuticals misses by $0.20, misses on revenue
04/26 Notable earnings after Wednesday?s close


Comments 
Advertisement
Chart VERTEX PHARMACEUTICALS INC
Duration : Period :
Vertex Pharmaceuticals Inc Technical Analysis Chart | VRTX | US92532F1003 | 4-Traders
Full-screen chart
Technical analysis trends VERTEX PHARMACEUT...
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions